Study Explores Drug Treatments for Early-onset Alzheimer’s disease

A recent clinical trial, funded in part by NIA, explored the impact of two drugs, gantenerumab or solanezumab, on symptoms and Alzheimer’s disease biomarkers among people with a rare type of early-onset dementia caused by genetic mutations. Researchers conducting the study…

Studies recruiting healthy volunteers, people with dementia or mild cognitive impairment

Interested in volunteering for research on Alzheimer’s, related dementias, and cognitive health? Search for clinical trials and studies near you with NIA’s Clinical Trials Finder. New and featured studies Click on the trial name for details, including contact information. Biomarkers and Brain…

As Science Evolves, So Do Study Sections

Study sections adapt to changing scienceRené Etcheberrigaray, Senior Scientific Advisor, Division of Extramural ActivitiesThe NIH Center for Scientific Review (CSR) reviews approximately 70% of the applications received by NIH, including those assigned to NIA. But as science advances, so must peer…

The Importance of Sleep in Healthy Aging, Commuting Patterns of Older Professionals, and More

Check out the latest in aging advances, research, and events happening at NIA: New report on indicators of well-being among older Americans — Federal agencies, including NIA, identified and updated 40 indicators of well-being in the areas of population, economics, health…